Navigation Links
BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
Date:6/12/2008

NEWARK, N.J., June 12 /PRNewswire/ -- BioNeutral announced today the results of tests utilizing its Ygiene(TM) formulation to kill anthrax spores on contact. This chemical technology is designed to be used by the military and first responders in conjunction with any suspected anthrax exposure. "The Ygiene(TM) formulation killed all anthrax spores exposed to the formulation in as little as 15 seconds," said Dr. Philip Tierno, the Principal Investigator on the project. Dr. Tierno is the Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. "This is an extraordinary result given the heartiness and particular difficulty in eradicating anthrax spores. The test compared results with a 10% solution of chlorine bleach which required almost 100 times the contact time to achieve the same test result. I expect this chemical technology will be used in applications which will prove beneficial, even life-saving, in hospital and other healthcare settings."

Dr. Andy Kielbania, Chief Scientist for BioNeutral, said, "We are currently continuing our corrosive and stability testing. As demonstrated by these exceptional results our combinational technology platform allows us to develop formulations that can deliver active ingredients with exceptional speed and pinpoint efficacy."

Mr. Raj Pamani, a member of the Board of Directors, said, "We look forward to introducing this technology to the Department of Homeland Security, Department of Defense and the City and State's Task Force on Bioterrorism."

About BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. T
'/>"/>

SOURCE BioNeutral Laboratories Corporation
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related biology technology :

1. Indevus Announces Management Changes
2. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
3. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
4. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
5. Veridex Announces Agreement to Acquire the Assets of Immunicon Corporation
6. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
7. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
8. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
9. Appature Announces onKey as an Innovative Platform for Creating Microsoft HealthVault-Compatible Applications
10. Premier Research Announces Completion of Management Buyout
11. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...if., Dec. 4 BlueFire Eth...pany focused on changing the world,s transportatio...from non-food cellulosic wastes, has been ranked n...Hottest Companies in Bioenergy;" the company,s sec... voters rank BlueFire Ethanol among the top 20 bio...
(Date:12/3/2009)..., Dec. 3 Shire plc (LSE:...armaceutical company, today announced a voluntary ...l of one lot of the Attention-Deficit/Hyperactivit... taking this action because some Daytrana patches ...lease liner removal specification, and as a result...
(Date:12/2/2009)...d., Dec. 2 Martek Biosci... that it intends to release the results of its fou...009, at approximately 4:00 p.m. Eastern Time (ET)....ll conduct a conference call to discuss these resu...sten to the call live via webcast by visiting Mart...
(Date:12/2/2009)...c. 2 Nearly 600 medical...nd funders today convened to explore novel develop...at the inaugural Partnering for Cures meeting. ...f the Milken Institute, convened Partnering for C...eded to turn a scientific discovery into an access...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...QC, Sept. 15 /PRNewswire-FirstCall/ - Neptune Tech...NEPT - TSX.V.NTB) reported today,that its distribu...ed,Schiff(R) MegaRed(TM) containing Neptune Krill ...gest retail pharmacy chain in the United States,wi...gaRed(TM) has been made,available at all locations...
...GO, Sept. 15 BioMed Realty Trust, Inc.,(NYSE: BM...s declared a,third quarter 2008 dividend of $0.335...lent to an annualized dividend of $1.34 per common...directors has declared a,dividend of $0.46094 per ...Redeemable Preferred Stock for the period from Jul...
...perts to Answer Questions about Attention Deficit ...(ADHD), NEW YORK, Sept. 12 The 10th annual ,ADHD...sday, September 17, 2008, from 8 a.m.,to midnight ... with,Attention Deficit Hyperactivity Disorder (AD...nity to ask questions and learn more about ADHD fr...
Other Biology Technology:Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 2Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 3BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 3Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 4Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 5Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 6
(Date:12/3/2009)...ALBUQUERQUE, N.M. Most scientists believe that st...that signal each other to emit toxins. The signali...acteria must be present to start the process. , ... that the very first stage of staph infection, whe...rm, occurs in a single cell and that this individu...
(Date:12/3/2009)...rest dwellers must be included in the design of th...void a humanitarian crisis, according to a scienti...in Nature , Dr Simon Lewis argues that at least 5...openhagen, known as REDD (Reducing Emissions from ...forest dwellers directly, and their property right...
(Date:12/3/2009)...e 30-year record low in Antarctic snowmelt that oc...y due to concurrent strong positive phases for two...illation) and SAM (Southern Hemisphere Annular Mod...essor of Earth & Atmospheric Sciences at The City ...is also on the doctoral faculty at the CUNY Gradua...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 1Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 2Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 3Gerresheimer Sells Technical Plastics Business 12861 1Gerresheimer Sells Technical Plastics Business 12861 2Triggering muscle development a therapeutic cure for muscle wastage 3F 9077 1
... has successfully protected mice and ferrets again...g to the investigator who led the study at St. Jud...veloped by Vical Incorporated in San Diego, Califo...ious studies that showed protection against multip...accine would protect humans against multiple varia...
...e water cycle and havens for wildlife, but they ar... in collaboration with the Ramsar Convention Secre...tellite imagery to provide detailed wide-area view... conservation efforts. , Because the success of we...dual wetland managers, the GlobWetland products an...
...experimental targeted therapy with a common anti-i... with advanced lung cancer, researchers at UCLA,s ...geted therapy Tarceva with the anti-inflammatory d...er patients by about three-fold, said Dr. Karen Re...gy and lead author of the study. The research appe...
Other Biology News:St. Jude test of bird flu vaccine proves successful 2African wetland managers armed with new technology 2Combination therapy shows promising results in patients with advanced lung cancer 2Combination therapy shows promising results in patients with advanced lung cancer 3
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Anti-Human sIL-2R / CD25 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Mouse Anti-Human STX18 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Human Lipid Phosphate Phosphohydrolase 2 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Biology Products: